Marco Archinti

565 total citations
8 papers, 459 citations indexed

About

Marco Archinti is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Marco Archinti has authored 8 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Marco Archinti's work include Protease and Inhibitor Mechanisms (4 papers), Peptidase Inhibition and Analysis (3 papers) and Microtubule and mitosis dynamics (3 papers). Marco Archinti is often cited by papers focused on Protease and Inhibitor Mechanisms (4 papers), Peptidase Inhibition and Analysis (3 papers) and Microtubule and mitosis dynamics (3 papers). Marco Archinti collaborates with scholars based in Spain, Italy and Germany. Marco Archinti's co-authors include Federico Furlan, Jens Lüders, Bernard Degryse, Gabriele Eden, Ronan P. Murphy, Cristina Lacasa, S. Arcioni, Monica Hasegan, Laurence Pelletier and Sally W.T. Cheung and has published in prestigious journals such as PLANT PHYSIOLOGY, Current Biology and Journal of Cell Science.

In The Last Decade

Marco Archinti

8 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Archinti Spain 7 341 237 91 73 63 8 459
Marcus M. Nalaskowski Germany 14 495 1.5× 170 0.7× 44 0.5× 69 0.9× 43 0.7× 25 634
Mahasin A. Osman United States 12 464 1.4× 227 1.0× 28 0.3× 60 0.8× 37 0.6× 19 576
William T. Wong United States 12 461 1.4× 168 0.7× 40 0.4× 88 1.2× 46 0.7× 12 657
Petr Folk Czechia 14 362 1.1× 166 0.7× 46 0.5× 60 0.8× 19 0.3× 28 526
Paul A. Mahoney United States 8 507 1.5× 212 0.9× 25 0.3× 57 0.8× 63 1.0× 9 621
Jennifer K. Yucel United States 9 608 1.8× 381 1.6× 82 0.9× 73 1.0× 47 0.7× 9 792
Sunita M. Gopalan United States 9 343 1.0× 36 0.2× 71 0.8× 62 0.8× 61 1.0× 9 436
Fredrik Noborn Sweden 15 419 1.2× 314 1.3× 50 0.5× 26 0.4× 60 1.0× 26 530
Eric Dumermuth Switzerland 8 188 0.6× 54 0.2× 102 1.1× 15 0.2× 33 0.5× 9 370
Michaela Niessen Germany 5 447 1.3× 109 0.5× 31 0.3× 93 1.3× 40 0.6× 6 569

Countries citing papers authored by Marco Archinti

Since Specialization
Citations

This map shows the geographic impact of Marco Archinti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Archinti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Archinti more than expected).

Fields of papers citing papers by Marco Archinti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Archinti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Archinti. The network helps show where Marco Archinti may publish in the future.

Co-authorship network of co-authors of Marco Archinti

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Archinti. A scholar is included among the top collaborators of Marco Archinti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Archinti. Marco Archinti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Furlan, Federico, Gabriele Eden, Marco Archinti, et al.. (2017). D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo. Peptides. 101. 17–24. 2 indexed citations
2.
Eden, Gabriele, Marco Archinti, Giuseppina Andreotti, et al.. (2017). D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR. Cellular and Molecular Life Sciences. 75(10). 1889–1907. 14 indexed citations
3.
Comartin, David, Gagan D. Gupta, Eden Fussner, et al.. (2013). CEP120 and SPICE1 Cooperate with CPAP in Centriole Elongation. Current Biology. 23(14). 1360–1366. 132 indexed citations
4.
Archinti, Marco, et al.. (2011). The Urokinase Receptor in the Central Nervous System. CNS & Neurological Disorders - Drug Targets. 10(2). 271–294. 34 indexed citations
5.
Eden, Gabriele, Marco Archinti, Federico Furlan, Ronan P. Murphy, & Bernard Degryse. (2011). The Urokinase Receptor Interactome. Current Pharmaceutical Design. 17(19). 1874–1889. 82 indexed citations
6.
Villén, Judit, Cristina Lacasa, M. Teresa Bertran, et al.. (2010). The γTuRC Revisited: A Comparative Analysis of Interphase and Mitotic Human γTuRC Redefines the Set of Core Components and Identifies the Novel Subunit GCP8. Molecular Biology of the Cell. 21(22). 3963–3972. 85 indexed citations
7.
Archinti, Marco, et al.. (2010). SPICE – a previously uncharacterized protein required for centriole duplication and mitotic chromosome congression. Journal of Cell Science. 123(18). 3039–3046. 17 indexed citations
8.
Mainieri, Davide, Marika Rossi, Marco Archinti, et al.. (2004). Zeolin. A New Recombinant Storage Protein Constructed Using Maize γ-Zein and Bean Phaseolin. PLANT PHYSIOLOGY. 136(3). 3447–3456. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026